---
title: "R&G Pharma shareholders HeXie ChengZhang Phase II and HeXie KangJian have cumulatively reduced their holdings by 2.1262 million shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/230846100.md"
description: "According to the Zhitong Finance APP, R&G Pharma announced that the company received a \"Notice on the Implementation of the Share Reduction Plan\" issued by HeXie ChengZhang Phase II and HeXie KangJian, stating that the above shareholders collectively reduced their holdings in the company by 2.1262 million shares"
datetime: "2025-03-06T14:19:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/230846100.md)
  - [en](https://longbridge.com/en/news/230846100.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/230846100.md)
generator: "portal-rs"
---

# R&G Pharma shareholders HeXie ChengZhang Phase II and HeXie KangJian have cumulatively reduced their holdings by 2.1262 million shares

According to the Zhitong Finance APP, R&G Pharma (301333.SZ) announced that the company received a "Notice on the Implementation of the Share Reduction Plan" issued by HeXie ChengZhang Phase II and HeXie KangJian, stating that the above shareholders have collectively reduced their holdings in the company by 2.1262 million shares

### Related Stocks

- [301333.CN](https://longbridge.com/en/quote/301333.CN.md)

## Related News & Research

- [US health agencies report 55 cases of E. coli and salmonella infections tied to alfalfa sprouts](https://longbridge.com/en/news/296645342.md)
- [Piller signs contract with Cosun Beet for V-RISE upgrade at Dutch sugar plant](https://longbridge.com/en/news/296751243.md)
- [03:20 ETMacGregor advances direct ship-to-well LCO₂ transfer, built on 50 years of proven bow-loading technology](https://longbridge.com/en/news/296749870.md)
- [Orum Therapeutics Announces U.S. FDA Clearance of an IND Application for ORM-1153, a Novel CD123-GSPT1 Degrader-Antibody Conjugate](https://longbridge.com/en/news/296689195.md)
- [Frozen blueberries recall categorized under FDA's highest Class I risk level](https://longbridge.com/en/news/296506599.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**